Dagatan, Mary Ann A.
HRN: 06-71-60 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2026
CEFTRIAXONE 1G (VIAL)
07/13/2026
07/20/2026
IV
1g
Q12
Lacerated Wound Sec To Self Inflicted Injury
Checking Final Appropriateness
07/13/2026
MUPIROCIN 2%, 15G (TUBE)
07/13/2026
07/20/2026
IV
1 Gram
Q12h
Lacerated Wound
Checking Final Appropriateness